Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Gabor Racz

Interventional Pain Medicine Lubbock, TX Medical Doctor

NPI 1871595124 CMS profile 130603

4515 Marsha Sharp Fwy, Lubbock, TX 79407

Open in the dashboard

General payments

$2,988,063

112 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Gabor Racz of Lubbock, TX is reported in the CMS Open Payments database as having received $2,988,063 across 112 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Interventional Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $504,706 25
2023 General $687,133 18
2022 General $445,174 17
2021 General $430,052 19
2020 General $415,982 15
2019 General $505,017 18

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gabor Racz
  • Interventional Pain Medicine median
  • Middle half of Interventional Pain Medicine
  • National median

In program year 2025, general payments to Gabor Racz were reported at $0. Among 1,891 Interventional Pain Medicine profiles paid that year, the median was $657 and the middle half received between $184 and $1,753.

Show as a table
Year Gabor Racz Interventional Pain Medicine median Middle half National median
2019 $505,017 $684 $216–$2,079 $163
2020 $415,982 $382 $122–$1,109 $114
2021 $430,052 $552 $167–$1,554 $132
2022 $445,174 $605 $187–$1,924 $149
2023 $687,133 $671 $195–$1,915 $160
2024 $504,706 $684 $206–$1,837 $164
2025 $0 $657 $184–$1,753 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Epimed International, Inc $2,746,944 95 payments
  2. Curonix LLC $240,098 2 payments
  3. Stimwave Technologies Incorporated $334 2 payments
  4. BIOTRONIK NRO, Inc. $148 2 payments
  5. Medtronic, Inc. $146 1 payment
  6. Boston Scientific Corporation $139 3 payments
  7. Nalu Medical, Inc. $80 4 payments
  8. SPR Therapeutics, Inc $78 1 payment
  9. AbbVie, Inc. $50 1 payment
  10. Nevro Corp. $45 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Royalty or License $2,240,363 24 payments
  2. Consulting Fee $506,492 70 payments
  3. Acquisitions $240,000 1 payment
  4. Food and Beverage $1,208 17 payments
Products named General payments · program years 2019–2024
  1. Catheters and Needles $2,026,985 74 payments
  2. Epidural Needles and Catheters $497,356 16 payments
  3. Needles and Catheters $327,377 5 payments
  4. Epidural Needle and Catheter $7,346 1 payment
  5. Prospera $148 2 payments
  6. INTELLIS $146 1 payment
  7. WaveWriter Alpha Prime 16 $139 3 payments
  8. PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A $98 1 payment
  9. Nalu Neurostimulation System $80 4 payments
  10. SPRINT PNS System $78 1 payment
  11. Other $184 7 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

112 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Pain Medicine in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record